Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26522334

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Dec
First author
Wilkins A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Dec;16(16):1570-1. doi: 10.1016/S1470-2045(15)00364-2.
    note
    Source null
    related pmid
    26522335
    relationship
    Comment in
  2. citation
    J Urol. 2016 Nov;196(5):1445-1447. doi: 10.1016/j.juro.2016.08.067.
    note
    Source null
    related pmid
    27751451
    relationship
    Comment in

Authors and identifiers

  1. name
    Wilkins A
    type
    Author
  2. name
    Mossop H
    type
    Author
  3. name
    Syndikus I
    type
    Author
  4. name
    Khoo V
    type
    Author
  5. name
    Bloomfield D
    type
    Author
  6. name
    Parker C
    type
    Author
  7. name
    Logue J
    type
    Author
  8. name
    Scrase C
    type
    Author
  9. name
    Patterson H
    type
    Author
  10. name
    Birtle A
    type
    Author
  11. name
    Staffurth J
    type
    Author
  12. name
    Malik Z
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Wilkins A
    type
    Author
  2. name
    Mossop H
    type
    Author
  3. name
    Syndikus I
    type
    Author
  4. name
    Khoo V
    type
    Author
  5. name
    Bloomfield D
    type
    Author
  6. name
    Parker C
    type
    Author
  7. name
    Logue J
    type
    Author
  8. name
    Scrase C
    type
    Author
  9. name
    Patterson H
    type
    Author
  10. name
    Birtle A
    type
    Author
  11. name
    Staffurth J
    type
    Author
  12. name
    Malik Z
    type
    Author
bibliography ids
  1. nci-bib-79b9a6f180de8dbde0dd9490
book metadata
content sha256
4961f75e1dc0334c2076e2e04dde788ac40d3b993b32052acc7da785e642c6a9
document type
citation
dois
  1. 10.1016/S1470-2045(15)00280-6
electronic publication date
display
2015 Oct 28
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26522334
immutable id
pubmed:26522334@4961f75e1dc0334c2076e2e04dde788ac40d3b993b32052acc7da785e642c6a9
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
16
name
The Lancet. Oncology
nlm unique id
100957246
pages
1605-16
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Dec;16(16):1570-1. doi: 10.1016/S1470-2045(15)00364-2.
    note
    Source null
    related pmid
    26522335
    relationship
    Comment in
  2. citation
    J Urol. 2016 Nov;196(5):1445-1447. doi: 10.1016/j.juro.2016.08.067.
    note
    Source null
    related pmid
    27751451
    relationship
    Comment in
outcomes validated
false
pmid
26522334
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
80ee37f1d32150ba2865c503941235d4c61d86972d93e62eefebd3b4824de598
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2015 Dec
precision
month
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26522334/
title
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.

Preserved source evidence · Not medical advice